JPS62161791A - ２−メチルチアゾロ（４，５−ｃ）キノリン誘導体よりなる薬剤、その製造方法及びそれを使用した中枢神経抑制剤 - Google Patents

２−メチルチアゾロ（４，５−ｃ）キノリン誘導体よりなる薬剤、その製造方法及びそれを使用した中枢神経抑制剤

Info

Publication number
JPS62161791A
JPS62161791A JP61267868A JP26786886A JPS62161791A JP S62161791 A JPS62161791 A JP S62161791A JP 61267868 A JP61267868 A JP 61267868A JP 26786886 A JP26786886 A JP 26786886A JP S62161791 A JPS62161791 A JP S62161791A
Authority
JP
Japan
Prior art keywords
methylthiazolo
acid addition
quinoline
compound
addition salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP61267868A
Other languages
English (en)
Japanese (ja)
Inventor
ヨージェフ　クノル
エディト　ベレーニィ　ネーエ　ポルデルマン
カタリン　ブダイ　ネーエ　シモニィ
ベルタ　クノル
ジュザァ　フュルツ
ユリア　ティマール
ガブリエラ　ジュイラ
イルディコー　ニクリュア
ルイザ　ペトオェーツ
アッティラ　マーンディ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egyt Gyogyszervegyeszeti Gyar
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of JPS62161791A publication Critical patent/JPS62161791A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP61267868A 1985-11-12 1986-11-12 ２−メチルチアゾロ（４，５−ｃ）キノリン誘導体よりなる薬剤、その製造方法及びそれを使用した中枢神経抑制剤 Pending JPS62161791A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU2251-4302/85 1985-11-12
HU854302A HU196308B (en) 1985-11-12 1985-11-12 Process for producing pharmaceutical compositions containing 2-methyl-thiazolo/4,5-c/quinoline as active component

Publications (1)

Publication Number Publication Date
JPS62161791A true JPS62161791A (ja) 1987-07-17

Family

ID=10967583

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61267868A Pending JPS62161791A (ja) 1985-11-12 1986-11-12 ２−メチルチアゾロ（４，５−ｃ）キノリン誘導体よりなる薬剤、その製造方法及びそれを使用した中枢神経抑制剤

Country Status (15)

Country Link
US (1) US4778811A (https=)
JP (1) JPS62161791A (https=)
AU (1) AU587505B2 (https=)
BE (1) BE905718A (https=)
CH (1) CH669729A5 (https=)
DE (1) DE3638573A1 (https=)
FR (1) FR2589733A1 (https=)
GB (1) GB2182561B (https=)
HU (1) HU196308B (https=)
IL (1) IL80609A0 (https=)
IT (1) IT1214558B (https=)
NL (1) NL8602877A (https=)
SE (1) SE8604838L (https=)
YU (1) YU192086A (https=)
ZA (1) ZA868582B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU197019B (en) * 1985-11-12 1989-02-28 Egyt Gyogyszervegyeszeti Gyar Process for producing thiqzolo (4,5-c) quinoline derivatives and pharmaceuticals comprising same
HU199423B (en) * 1987-04-24 1990-02-28 Egyt Gyogyszervegyeszeti Gyar Process for producing 3-amino-4-/ethylthio/-quinoline and pharmaceutical compositions comprising such compounds
US4831040A (en) * 1988-02-01 1989-05-16 Rorer Pharmaceutical Corporation Method of prevention and treatment of peptic ulcers
US6110929A (en) 1998-07-28 2000-08-29 3M Innovative Properties Company Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666916A (en) * 1985-11-08 1987-05-19 Ciba-Geigy Corporation Hexahydro-(1)-benzo-(pyrano and thiopyrano) (4,3-C)pyridines, useful as serotin-2 blocking agents

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J.AM.CHEM.SOC=1947 *

Also Published As

Publication number Publication date
AU587505B2 (en) 1989-08-17
GB2182561B (en) 1989-12-06
US4778811A (en) 1988-10-18
AU6508686A (en) 1987-05-14
HU196308B (en) 1988-11-28
HUT44562A (en) 1988-03-28
IL80609A0 (en) 1987-02-27
IT8622313A0 (it) 1986-11-12
SE8604838L (sv) 1987-05-13
GB2182561A (en) 1987-05-20
NL8602877A (nl) 1987-06-01
ZA868582B (en) 1987-07-29
CH669729A5 (https=) 1989-04-14
DE3638573A1 (de) 1987-05-14
FR2589733A1 (fr) 1987-05-15
SE8604838D0 (sv) 1986-11-12
BE905718A (fr) 1987-05-07
GB8627042D0 (en) 1986-12-10
YU192086A (en) 1987-12-31
IT1214558B (it) 1990-01-18

Similar Documents

Publication Publication Date Title
SU1544190A3 (ru) Способ получени тиазоло [4,5-с] хинолина или его кислотно-аддитивных солей
BG61367B2 (bg) Циклоалкилтриазоли
CN109748881A (zh) 胱硫醚-γ-裂合酶(CSE)抑制剂
KR101630467B1 (ko) 진통 내성 억제제
KR950010148B1 (ko) 중독증 치료용 의약품
US11141404B1 (en) Formulations and methods for treating acute cannabinoid overdose
JPS6399073A (ja) １−（４−アミノフェニル）−４−メチル−７，８−メチレンジオキシ−３，４−ジヒドロ−５ｈ−２，３−ベンゾジアゼピン、その光学活性体およびラセミ体、および前記化合物の酸付加塩、その製造方法、並びに前記化合物を含む薬剤、その製造方法、およびそれによる治療方法
GB2243832A (en) 2-substituted 4-acetamido-5-chloro-n-[2-(diethylamino)ethyl]-benzamide derivative
JPH0354922B2 (https=)
JPS62161791A (ja) ２−メチルチアゾロ（４，５−ｃ）キノリン誘導体よりなる薬剤、その製造方法及びそれを使用した中枢神経抑制剤
US10604485B2 (en) Hydrobromide salt of N-(4-chloro-2-hydroxy-3-((3S)-3-piperidinylsulfonyl)phenyl-N′-(3-Fluoro-2-methylphenyl)urea
US3709996A (en) Pharmaceutical compositions containing n-cyclopropyl-1-aminoindane compounds and adapted for administration to obtain inhibition of monoamine oxidase enzyme and process
TW200940543A (en) Maleate, besylate and L-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
EP0788795A4 (en) PHARMACOLOGICALLY ACTIVE 2-MERCAPTOBENZIMIDAZOLE DERIVATIVES
US4115571A (en) 10-(Bis-pyrrolinyl) phenoxazines
RU2073678C1 (ru) (s)-1-[(10-хлор-6,7-дигидро-4-оксо-3-фенил-4h-бензо/а/хинолизин-1-ил)карбонил]-3-этоксипирролидин, (s)-1-[(10-хлор-6,7-дигидро-4-оксо-3-фенил-4h-бензо/а/хинолизин-1-ил)карбонил]-3-оксипирролидин в качестве промежуточного продукта, композиция, обладающая гипнотическим неседативным действием
US2807617A (en) Acylpiperazines and methods of preparing the same
CA1087987A (en) Pharmaceutical composition containing 3- phenoxypyridine
HUT68215A (en) Use of 5ht1a receptor antagonist compounds for production of antitobacco medicament
DE2000775B2 (de) Substituierte 1,2,3,4-Tetrahydrobenzothieno [23-c] pyridin-Verbindungen, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitung, die diese Verbindungen enthält
DE1770135A1 (de) Verfahren zur Herstellung von 2,4-Benzdiazepinen
CN115433116B (zh) 一种酰化吲哚啉类衍生物、组合物及其应用
US2991225A (en) Omicron-methylbenzhydryl-beta-dimethylaminoethyl ether process and composition for symptomatic relief of the syndrome of parkinsonism and of spastic skeletal muscle disorders
JPH07503240A (ja) ３‐アリールインドールおよび１‐アリールインダゾール誘導体の精神病の治療のための使用
KR100556559B1 (ko) 2-(4-(4-(4,5-디클로로-2-메틸이미다졸-1-일)부틸)-1-피페라지닐)-5-플루오로피리미딘, 이것의 제조 방법 및 이것의치료적 용도